Krystal Biotech Inc (KRYS) — Net Asset Quality Index
Krystal Biotech Inc (KRYS) has a Net Asset Quality Index of 91.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.40 Billion minus total liabilities of $120.24 Million yields net assets of $1.28 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Krystal Biotech Inc (KRYS) liquidity interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Krystal Biotech Inc Net Asset Quality Index Over Time (2016–2025)
This chart shows how Krystal Biotech Inc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the index stands at 91.4%, representing net assets of $1.28 Billion against total assets of $1.40 Billion USD. Explore Krystal Biotech Inc (KRYS) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Krystal Biotech Inc (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Krystal Biotech Inc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Krystal Biotech Inc market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 91.4% | $1.22 Billion | $1.33 Billion | $114.23 Million | ▲ +1.8 pp |
| 2024 | 89.6% | $946.38 Million | $1.06 Billion | $109.46 Million | ▼ -5.5 pp |
| 2023 | 95.1% | $778.64 Million | $818.36 Million | $39.71 Million | ▲ +1.6 pp |
| 2022 | 93.5% | $522.23 Million | $558.45 Million | $36.22 Million | ▼ -1.3 pp |
| 2021 | 94.8% | $593.58 Million | $626.29 Million | $32.72 Million | ▲ +0.8 pp |
| 2020 | 94.0% | $292.08 Million | $310.84 Million | $18.76 Million | ▼ -3.1 pp |
| 2019 | 97.1% | $202.91 Million | $209.02 Million | $6.11 Million | ▼ -0.4 pp |
| 2018 | 97.5% | $113.23 Million | $116.12 Million | $2.89 Million | ▼ -1.2 pp |
| 2017 | 98.7% | $49.47 Million | $50.11 Million | $640.00K | ▲ +85.5 pp |
| 2016 | 13.2% | $289.00K | $2.18 Million | $1.89 Million | — |